Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Skin Cancer

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Skin Cancer

Nishad C. Sathe et al.
Free Books & Documents

Excerpt

Skin neoplasms are one of the most common diagnoses among patient encounters. Evaluating both benign and malignant neoplasms is vital, particularly due to the increasing incidence of skin cancers and complications associated with the condition. Skin cancer has multiple etiologic factors, with UV radiation-induced DNA damage and oncogenesis being the most prominent. Preventive strategies, such as sunscreen application, are essential in reducing risk. After evaluation by a trained healthcare provider, a biopsy is typically performed, and histopathological evaluation helps confirm the diagnosis and differentiate the type of skin cancer from other conditions. Management of skin cancer may involve observation, topical therapies, local non-topical treatments (eg, antineoplastic medication injections), systemic regimens (eg, chemotherapy and immunotherapy), radiation therapy, and surgical or procedural interventions (eg, Mohs micrographic surgery and cryosurgery).

The skin's anatomical complexity allows skin cancer to arise from any of its cells or components. The proliferation of cells in skin cancer can be benign or malignant (see Image. Anatomy of the Human Skin). Please see StatPearls' companion resource, "Anatomy, Skin (Integument)," for more information on skin anatomy. In standard literature, malignant skin cancer is typically categorized into melanoma and nonmelanoma skin cancers, which usually refer to basal cell carcinoma or squamous cell carcinoma. However, this classification can be problematic, as skin cancer can originate from various cells and subdivisions of the skin.

Benign epidermal tumors may include epidermal nevi, pseudoepitheliomatous hyperplasia (eg, prurigo nodularis), and acanthomas (eg, seborrheic keratosis). Premalignant dysplasia, such as actinic keratosis and arsenical keratosis, may also be present. Malignant tumors of the epidermis include intraepidermal carcinoma (eg, Bowen disease), basal cell carcinoma, squamous cell carcinoma, and verrucous carcinoma. Please see StatPearls' companion resources, "Seborrheic Keratosis," "Clear Cell Acanthoma," "Cutaneous Horn," "Keratoacanthoma," "Cutaneous Melanoacanthoma," "Cutaneous Squamous Cell Carcinoma," "Intraepidermal Carcinoma," and "Basal Cell Carcinoma," for more information on common epidermal tumors.

Pigmentary lesions include those with basal melanocytic proliferation (eg, solar lentigo), junctional or dermal melanocytic lesions (eg, Spitz nevus), dysplastic lesions (eg, dysplastic nevus), and malignant lesions (eg, melanoma, clear cell sarcoma). Please see StatPearls' companion resources, "Subungual Melanoma," "Lentigo Maligna Melanoma," "Metastatic Melanoma," "Dysplastic Nevi," "Atypical Mole," "Acral Lentiginous Melanoma," and "Congenital Melanocytic Nevi," for more information on pigmentary lesions relevant to skin cancer.

Skin cancer may arise from cutaneous appendages, such as hair follicles (eg, desmoplastic trichoepithelioma), sebaceous glands (eg, sebaceous adenoma and sebaceous carcinoma), apocrine glands (eg, spiradenoma), and eccrine glands (eg, porocarcinoma). Please see StatPearls' companion resources, "Desmoplastic Trichoepithelioma," "Sebaceous Carcinoma," "Syringoma," "Spiradenoma," "Trichoblastoma and Trichoepithelioma," and "Cylindroma," for more information on tumors of cutaneous appendages.

Fibrous tissues of the skin can also proliferate, leading to skin cancer, such as dermatofibroma and its malignant counterpart, dermatofibrosarcoma protuberans. Please see StatPearls' companion resources, "Dermatofibrosarcoma Protuberans" and "Dermatofibroma," for more information on fibrous tumors.

The presence of fat, muscle, cartilage, and bone can lead to skin cancers such as liposarcoma, leiomyosarcoma, chondroma, and osteosarcoma (although osteosarcoma may be considered metastatic by some). Please see StatPearls' companion resources, "Atypical Fibroxanthoma" and "Leiomyosarcoma," for more information on fat, muscle, cartilage, and bone tumors.

Benign and malignant skin cancers can arise from neural tissue, such as Merkel cell carcinoma and schwannoma, or from vascular tissue, such as hemangioma and angiosarcoma. Please see StatPearls' companion resources, "Angiolymphoid Hyperplasia With Eosinophilia," "Angiosarcoma," "Merkel Cell Carcinoma of the Skin," "Neurothekeoma," "Hemangioma," "Cutaneous Vascular Malignancies," "Angiosarcoma," " Kaposi Sarcoma," and "Cutaneous Angiofibroma," for more information on common tumors of neural and vascular origin.

Infiltrative skin cancers can arise from various immune cells that reside in the skin, including mastocytoma, xanthoma, Langerhans cell histiocytosis, T-cell lymphoma, natural killer (NK)—cell lymphoma, and B-cell lymphoma. Please see StatPearls' companion resources "Sezary Syndrome," "Extranodal NK-Cell Lymphoma," "Peripheral T-Cell Lymphoma," "Dermatopathology Evaluation of Cysts," "Mastocytoma," "Mycosis Fungoides," and "Lymphomatoid Papulosis," for more information.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Nishad Sathe declares no relevant financial relationships with ineligible companies.

Disclosure: Patrick Zito declares no relevant financial relationships with ineligible companies.

References

    1. Aggarwal P, Knabel P, Fleischer AB. United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. J Am Acad Dermatol. 2021 Aug;85(2):388-395. - PubMed
    1. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 2015 Oct;151(10):1081-6. - PubMed
    1. Glazer AM, Winkelmann RR, Farberg AS, Rigel DS. Analysis of Trends in US Melanoma Incidence and Mortality. JAMA Dermatol. 2017 Feb 01;153(2):225-226. - PubMed
    1. Haddad S, Weise JJ, Wagenpfeil S, Vogt T, Reichrath J. Malignant Melanoma: Vitamin D Status as a Risk and Prognostic Factor - Meta-analyses and Systematic Review. Anticancer Res. 2025 Jan;45(1):27-37. - PubMed
    1. Elston DM, Stratman EJ, Miller SJ. Skin biopsy: Biopsy issues in specific diseases. J Am Acad Dermatol. 2016 Jan;74(1):1-16; quiz 17-8. - PubMed

Publication types

LinkOut - more resources